From USFDA
Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Tacrolimus Ointment, 0.1%, the generic version of Protopic1 Ointment, 0.1%, of Leo Pharma AS.According to IQVIATM sales data for the 12 month period ending February 2018, the Protopic Ointment, 0.1% market2 achieved annual sales of approximately $109.0 million*.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
